Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/01/09/2806254/37000/en/Organovo-To-Present-FXR314-IBD-3D-Model-Findings-at-Upcoming-Crohn-s-and-Colitis-Congress.html
https://www.globenewswire.com//news-release/2023/11/13/2779037/37000/en/CORRECTION-Organovo-Highlights-FXR314-Combination-Therapy-Potential-and-Plan.html
https://www.globenewswire.com//news-release/2023/09/08/2740276/37000/en/Organovo-to-Participate-in-the-H-C-Wainwright-Global-Investment-Conference.html
https://www.globenewswire.com//news-release/2023/08/23/2730387/37000/en/Organovo-Advances-Clinical-Timelines-for-FXR314-and-Provides-Updates-on-NASH-Phase-2-Data.html
https://www.globenewswire.com/news-release/2023/03/21/2631267/37000/en/Organovo-Announces-FXR-Program.html
https://www.globenewswire.com/news-release/2022/11/15/2556140/37000/en/Organovo-Announces-Target-Validation-Ahead-of-Schedule-Accelerating-Timeline-for-First-Crohn-s-Disease-Drug-Candidates.html
https://www.globenewswire.com/news-release/2022/09/06/2510390/37000/en/Organovo-to-Participate-in-the-H-C-Wainwright-24th-Annual-Global-Investment-Conference.html
https://www.globenewswire.com/news-release/2022/05/17/2444954/37000/en/Organovo-Achieves-3D-Tissue-Model-for-Crohn-s-Disease.html
https://www.globenewswire.com/news-release/2022/03/01/2394293/37000/en/UPDATE-Organovo-and-BICO-CELLINK-Reach-Licensing-Agreement-on-Bioprinting-Patents.html
https://www.globenewswire.com/news-release/2022/02/23/2390343/37000/en/Organovo-and-BICO-CELLINK-Reach-Licensing-Agreement-on-Bioprinting-Patents.html